Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study
The study's glucose management approach using CGM did not improve glucose levels compared with standard glucose management in the non-intensive care unit hospital setting. A glucose target of 90-130 mg/dL may not be realistic in the current environment of insulin management in the hospital.
Authors
- David Clinton McNabb
- Jing H. Chao
- Karla Fulghum
- Shari L. Reynolds
- Bobak Moazzami (ORCID: https://orcid.org/0000-0001-7322-3369)
- Amanda Henry (ORCID: https://orcid.org/0000-0002-7351-8922)
- Georgia M. Davis (ORCID: https://orcid.org/0000-0001-9671-0063)
- Jesica D. Baran
- Irl B. Hirsch (ORCID: https://orcid.org/0000-0003-1675-8417)
- Dan Raghinaru
- Dori Khakpour
- Ildi Lingvay
- Julie Davis
- Judy Sibayan (ORCID: https://orcid.org/0009-0005-9298-133X)
- Janet B. McGill (ORCID: https://orcid.org/0000-0002-6228-6521)
- Boris Draznin (ORCID: https://orcid.org/0000-0001-7148-9518)
- Russell Guzzetta
- Cecilia C. Low Wang (ORCID: https://orcid.org/0000-0001-8557-5417)
- Stacey Seggelke (ORCID: https://orcid.org/0000-0002-3653-8166)
- Priyathama Vellanki (ORCID: https://orcid.org/0000-0002-6544-015X)
- Guillermo E. Umpierrez (ORCID: https://orcid.org/0000-0002-3252-5026)
- Brooke C. Matson (ORCID: https://orcid.org/0000-0003-1979-1562)
- April Goley
- Jamie Diner
- Eduardo Rial (ORCID: https://orcid.org/0000-0001-8634-8902)
- Francisco J. Pasquel (ORCID: https://orcid.org/0000-0002-3845-6703)
- Jesica Baran
- Victoria Hudson (ORCID: https://orcid.org/0000-0002-7370-0118)
- Jennifer Vinh
- Zohyra E. Zabala (ORCID: https://orcid.org/0000-0003-4208-6087)
- Alex Kass
- W. Norman Scott (ORCID: https://orcid.org/0000-0002-1051-9952)
- Nikola Gligorijevic
- Erin E. Kershaw (ORCID: https://orcid.org/0000-0002-3887-4868)
- Becky Alexander (ORCID: https://orcid.org/0000-0001-9915-4621)
- Chase Armstrong
- Elias K. Spanakis (ORCID: https://orcid.org/0000-0002-9352-7172)
- Ruth S. Weinstock (ORCID: https://orcid.org/0000-0001-5859-5666)
- Roy W. Beck (ORCID: https://orcid.org/0000-0002-5194-8446)
- Paige Graham
- Klara R. Klein (ORCID: https://orcid.org/0000-0002-5894-9054)
- Ashish Garg (ORCID: https://orcid.org/0000-0003-4544-7036)
- Lakshmi G. Singh
- Jagdeesh Ullal
- José A. Vázquez (ORCID: https://orcid.org/0000-0001-5774-819X)
- Craig Kollman (ORCID: https://orcid.org/0009-0008-6696-0334)
- Morgan Jones (ORCID: https://orcid.org/0009-0001-0493-0104)
- Rachael Fraser
- M. Huang
- Craig Kollman
- Cassandra Donahue
- Carlos Vélez
- Monica Y. Choe
- Wanda Ferrara
- Faryal Gilani
- Jade Churchill
- Joseph O. Monye
- Rajlaxmi Bais
- Whitney B. Adair
- Palak Choksi (ORCID: https://orcid.org/0000-0002-1860-6858)
- Charles Spanbauer
- Camille Ubas
- Sirisha Ravulapally
- Catherine Morba
Institutions
- University of North Carolina at Chapel Hill (US)
- University of Maryland, Baltimore (US)
- Emory University (US)
- University of Pittsburgh (US)
- University of Washington (US)
- Jaeb Center for Health Research (US)
- Baltimore VA Medical Center (US)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2024-11-21
- DOI
- https://doi.org/10.2337/dc24-1779
- Citations
- 16
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 5.72
Funders
- U.S. Department of Veterans Affairs
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Emory University
- Regeneron Pharmaceuticals
- Vertex Pharmaceuticals
- Bigfoot Biomedical
- Insulet Corporation
- MannKind Corporation
- Dexcom
- Tandem Diabetes Care
- Moderna
- Novo Nordisk
- National Institutes of Health
- University of North Carolina at Chapel Hill
- Abbott Diabetes Care
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Research Resources
- National Center for Advancing Translational Sciences